Compound Detail
CHEMBL3408947
OCIFISERTIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5C[C@@H](C)O[C@@H](C)C5)cc4)n[nH]c3c1)C(=O)N2
Basic Information
| ChEMBL ID | CHEMBL3408947 |
| Name | OCIFISERTIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | DADASRPKWOGKCU-FVTQAUBDSA-N |
14
Targets
33
Activities
3
Assay Types
16
PK Parameters
20
Publications
2
Known Names
1
Indications
1
Mechanisms
Molecular Properties
534.7
MW (Da)
5.73
ALogP
5
HBA
2
HBD
79.5
PSA (Ų)
0.33
QED
2
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serine/threonine-protein kinase PLK4 inhibitor | INHIBITOR | Serine/threonine-protein kinase PLK4 | ✓ | ✓ |
Indications
Neoplasms
Activity Summary
IC50 16 meas. best 8.55
EC50 15 meas. best 7.92
Ki 2 meas. best 9.59
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Serine/threonine-protein kinase PLK4 CHEMBL3788 | Ki | 9.59 | 9.59 | 0.3 | 2 |
| Serine/threonine-protein kinase PLK4 CHEMBL3788 | IC50 | 8.55 | 8.47 | 2.8 | 3 |
| High affinity nerve growth factor receptor CHEMBL2815 | IC50 | 8.22 | 8.22 | 6.0 | 1 |
| BDNF/NT-3 growth factors receptor CHEMBL4898 | IC50 | 8.05 | 8.05 | 9.0 | 1 |
| Serine/threonine-protein kinase PLK4 CHEMBL3788 | EC50 | 7.92 | 7.915 | 12.0 | 2 |
| Angiopoietin-1 receptor CHEMBL4128 | IC50 | 7.66 | 7.66 | 22.0 | 1 |
| High affinity nerve growth factor receptor CHEMBL2815 | EC50 | 7.08 | 7.08 | 84.0 | 2 |
| BDNF/NT-3 growth factors receptor CHEMBL4898 | EC50 | 7.06 | 7.06 | 88.0 | 2 |
| Aurora kinase B/Inner centromere protein CHEMBL3430907 | IC50 | 7.01 | 7.01 | 98.0 | 1 |
| Aurora kinase B CHEMBL2185 | EC50 | 6.99 | 6.99 | 102.0 | 2 |
| Aurora kinase B/Inner centromere protein CHEMBL3430907 | EC50 | 6.99 | 6.99 | 102.0 | 1 |
| Angiopoietin-1 receptor CHEMBL4128 | EC50 | 6.93 | 6.93 | 117.0 | 2 |
| Aurora kinase A CHEMBL4722 | IC50 | 6.85 | 6.85 | 140.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 6.33 | 6.33 | 466.0 | 1 |
| Aurora kinase A CHEMBL4722 | EC50 | 6.29 | 6.29 | 510.0 | 2 |
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | IC50 | 6.26 | 6.26 | 550.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.26 | 6.26 | 550.0 | 1 |
| Cytochrome P450 2C9 CHEMBL3397 | IC50 | 6.03 | 6.03 | 940.0 | 1 |
| Fibroblast growth factor receptor 1 CHEMBL3650 | EC50 | 5.96 | 5.96 | 1100.0 | 1 |
| Cytochrome P450 2C19 CHEMBL3622 | IC50 | 5.85 | 5.85 | 1400.0 | 1 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 5.51 | 5.425 | 3100.0 | 2 |
| SARS-CoV-2 CHEMBL4303835 | IC50 | 4.92 | 4.92 | 11910.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 9800.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 534.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 767.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 1054.0 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 3460.0 | ng.hr.mL-1 | Canis lupus familiaris |
| CL | 31.67 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 16.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| Cmax | 4114.76 | nM | Mus musculus |
| F | 21.0 | % | Rattus norvegicus |
| F | 66.0 | % | Canis lupus familiaris |
| T1/2 | 0.4 | hr | Mus musculus |
| T1/2 | 0.8833 | hr | Rattus norvegicus |
| T1/2 | 0.7167 | hr | Canis lupus familiaris |
| T1/2 | 1.0 | hr | Homo sapiens |
| T1/2 | 2.0 | hr | Rattus norvegicus |
| T1/2 | 2.1 | hr | Canis lupus familiaris |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 25723005 | 10.1021/jm5005336 | NON-PROTEIN TARGET | 10 |
| 25723005 | 10.1021/jm5005336 | Canis familiaris | 5 |
| 25723005 | 10.1021/jm5005336 | Rattus norvegicus | 5 |
| 25723005 | 10.1021/jm5005336 | Mus musculus | 5 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 25723005 | 10.1021/jm5005336 | MDA-MB-468 | 3 |
| 25723005 | 10.1021/jm5005336 | Serine/threonine-protein kinase PLK4 | 3 |
| 25791677 | 10.1016/j.ejmech.2015.03.020 | Serine/threonine-protein kinase PLK4 | 3 |
| 25723005 | 10.1021/jm5005336 | A549 | 3 |
| 25723005 | 10.1021/jm5005336 | Liver microsome | 3 |
| 25723005 | 10.1021/jm5005336 | Aurora kinase A | 2 |
| 25723005 | 10.1021/jm5005336 | Aurora kinase B/Inner centromere protein | 2 |
| 25723005 | 10.1021/jm5005336 | Cytochrome P450 3A4 | 2 |
| 25723005 | 10.1021/jm5005336 | Angiopoietin-1 receptor | 2 |
| - | 10.6019/CHEMBL4495565 | ADMET | 2 |
| 25723005 | 10.1021/jm5005336 | High affinity nerve growth factor receptor | 2 |
| 25723005 | 10.1021/jm5005336 | BDNF/NT-3 growth factors receptor | 2 |
| - | 10.6019/CHEMBL4495565 | Vero C1008 | 2 |
| - | 10.6019/EOS300033 | SARS-CoV-2 | 1 |
| 25723005 | 10.1021/jm5005336 | HMEC | 1 |
Data from ChEMBL 36 via Core Engine